Conagra sees 'opportunity' to sell frozen meals to those on weight loss
drugs
Send a link to a friend
[February 21, 2024]
By Jessica DiNapoli
NEW YORK (Reuters) - U.S. packaged foods firm Conagra Brands sees an
"opportunity" to sell more frozen meals, meat snacks and popcorn to
people using weight-loss drugs like Ozempic, executive Tom McGough said
Tuesday at an industry conference.
Investors have worried that U.S. food companies will see sales slide as
more people use weight-loss drugs like Ozempic and Wegovy, which curb
appetite and lead to feelings of fullness.
Chicago-based Conagra, which makes Healthy Choice frozen meals, Bertolli
Italian foods, and Duncan Hines cake mixes, previously said it may have
to scale down portions to court consumers using the medications.
"If anything, we see opportunity within our portfolio," McGough said at
the Consumer Analyst Group of New York Conference in Boca Raton,
Florida.
He said that data from market research firm Numerator shows that
consumption of "better-for-you" frozen meals increases 8% among people
using the weight-loss drugs.
"Well, why is that? Well, frozen meals are portion-controlled," McGough
said. "They provide vegetable nutrition and they're high in protein."
McGough also expects users of the weight-loss medications, called "GLP-1
agonists," to eat more of the company's snacks like Slim Jim beef jerky
and Angie's Boomchickapop popcorn.
![](http://archives.lincolndailynews.com/2023/Nov/22/images/ads/current/llc_sda_BASKETBALL_2023.png)
[to top of second column]
|
![](../images/022124PIX/health21.jpg)
Packets of Birds Eye foods, a brand owned by Conagra Brands, are
seen in a store in Manhattan, New York, U.S., November 15, 2021.
REUTERS/Andrew Kelly/File Photo
![](http://archives.lincolndailynews.com/2024/Feb/21/images/ads/current/debbiesfloral_lda_021424.png) "That's because meat snacks are high
in protein and popcorn is a low-calorie, high-fiber food and among
GLP-1 users, consumption of both meat snacks and popcorn increase,"
he said.
Conagra's competitors, including Kraft Mac and Cheese maker Kraft
Heinz and Pringles manufacturer Kellanova, may also face questions
from Wall Street analysts on the impact of the drugs on their sales
at the conference.
General Mills CEO Jeffrey Harmening said at the conference that his
company was introducing new products to "meet evolving consumer
weight management and nutrition needs."
Annie's Macaroni & Cheese has a new "Super Mac" offering with more
protein, for instance, while General Mills is also launching "a
protein-forward Progresso soup line and bringing lower sugar
offerings to our Betty Crocker cakes, cookies and brownies,"
Harmening said.
(Reporting by Jessica DiNapoli in New York, Editing by Rosalba
O'Brien)
[© 2024 Thomson Reuters. All rights reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |